Onderneming Acasti Pharma Inc Toronto S.E.
Aandelen
APO
CA00430K4028
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01-08-21 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08-05-23 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 08-05-23 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 15-05-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10-10-23 |
Director/Board Member | - | 10-10-23 | |
Santosh Kottayil
BRD | Director/Board Member | - | 10-10-23 |
Chairman | 55 | 27-08-21 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 9 399 404 | 7 893 546 ( 83,98 %) | 0 | 83,98 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |